citation,pmid
"Furge KA, Zhang YW, Vande Woude GF. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene. 2000 Nov 20;19(49):5582–9.",11114738
"Giubellino A, Linehan WM, Bottaro DP. Targeting the Met signaling pathway in renal cancer. Expert Rev Anticancer Ther. 2009 Jun;9(6):785–93.",19496715
"Cecchi F, Rabe DC, Bottaro DP. Targeting the HGF/Met signalling pathway in cancer. Eur J Cancer. 2010 May;46(7):1260–70.",20303741
Appleman LJ. MET signaling pathway: a rational target for cancer therapy. J Clin Oncol. 2011 Dec 20;29(36):4837–8.,22042966
"Organ SL, Tsao M-S. An overview of the c-MET signaling pathway. Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S7–19.",22128289
"Fay AP, Signoretti S, Choueiri TK. MET as a target in papillary renal cell carcinoma. Clin Cancer Res. 2014 Jul 1;20(13):3361–3.",24812413
"Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14;374(2):135–45.",26536169
